Bristol Myers Squibb Company
NEWS
This week MA-based real estate firm Calare Properties acquired the land and buildings for $5M.
Rumors of Nektar Therapeutics being up for sale may have been premature.
BMS shares climb more than 4% this morning after the company announced its anticipated Phase III CheckMate-227 study data.
The year is already off to a good start with mergers and acquisitions in the biopharma industry.
Here is a look at key takeaways from presentations made by four major pharma and biotech stocks at the annual J.P. Morgan healthcare conference.
These prominent drug developers look to be enticing buys this month.
The expense is primarily related to taxes on unremitted offshore earnings, the company said.
Immuno-oncology therapeutics have revolutionized certain types of cancer treatments, and they are, in many ways, as close to miracle cures as we’ve seen in decades.
There are hundreds, even thousands of biotech and pharmaceutical companies.
JOBS
IN THE PRESS